Caption Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding RGNX
Caption Management's RGNX Position: Q3 2026 in Review
Caption Management opened a new position in Regenxbio (RGNX) in Q3 2026: 14,400 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #1627 among its holdings. This is a return to the name: Caption Management previously reported a position in RGNX as recently as Q3 2025.
Caption Management first reported a position in RGNX in Q3 2020 and has held it in 9 quarters since. The position peaked at $289K in Q3 2020. 174 funds tracked by Wall St. Rank hold RGNX as of Q3 2026.
- Caption Management held 14,400 shares of Regenxbio worth $108K as of Q3 2026.
- Regenxbio was a new Caption Management position in Q3 2026.
- Regenxbio made up ﹤0.01% of Caption Management's portfolio in Q3 2026, its #1627 holding.
- Caption Management first reported a position in Regenxbio in Q3 2020 and has held it in 9 quarters since.
- Caption Management's Regenxbio position peaked at $289K in Q3 2020.
- 174 funds tracked by Wall St. Rank held Regenxbio as of Q3 2026.
Based on Caption Management's 13F filing for Q3 2026, filed 16 Nov 2026.